Tianjin Minxiang Biomedical Co., Ltd. (stock code: 834738) was founded in 2005 with registered capital of ¥67.3 million. It is a high-tech enterprise that engages in researching, developing and manufacturing biological medicines, chemical raw medicines, preparations, intermediates, and new drugs.
The company has many R&D staffs in chemical synthesis, development of chemical technology, detection and quality analysis. Moreover, the company has hired some experts to offering guidance in the fields of information collection, R&D, and scientific research cooperation.